Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Ovarian Cancer × olaparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 31 Breast Neoplasms 18 Neoplasms 9 Triple Negative Breast Neoplasms 8 Prostatic Neoplasms 6 Neoplasm Metastasis 6 Fanconi Anemia, Complementation Group D1 6 Sarcoma 5 Pancreatic Neoplasms 5 Endometrial Neoplasms 5 Small Cell Lung Carcinoma 4 Recurrence 4 Colorectal Neoplasms 4 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Fallopian Tube Neoplasms 3 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Metastatic Castration-resistant Prostate Cancer 2 Mesothelioma 2 Glioma 2 Central Nervous System Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Advanced Solid Tumours 2 Advanced Solid Tumors 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1

Interventions

talazoparib 1 olaparib 1 liposomal doxorubicin 1 Tranexamic Acid 1 Saline Solution 1 Observation 1 Neoadjuvant Therapy 1 Hyperthermic Intraperitoneal Chemotherapy 1 Carboplatin 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03161132 2023-01-27

ROLANDO

Grupo Español de Investigación en Cáncer de Ovario

Phase 2 Completed

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡